This finding indicates that the depletion of gut bacteria induced by antibiotics can counteract the therapeutic effect of CGA on NASH, thereby suggesting that the efficacy of CGA in treating NASH is contingent upon FXR functionality. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatohepatitis.